Dow Up 0.09% Nasdaq Up 0.03%

Celgene Corporation (CELG)

-NasdaqGS
94.98 Down 0.67(0.71%) 1:55PM EDT - Nasdaq Real Time Price
Prev Close:95.65
Open:96.15
Bid:94.98 x 100
Ask:94.99 x 200
1y Target Est:100.03
Beta:1.1
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:94.86 - 96.15
52wk Range:66.85 - 96.15
Volume:3,169,520
Avg Vol (3m):4,627,080
Market Cap:75.94B
P/E (ttm):30.23
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGDown 0.71%75.94B
JNJDown 0.35%290.72B

Key Statistics

Forward P/E (1 yr):19.43
P/S (ttm):10.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.67
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.99

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback